Alexis Retractor in Total Hip Arthroplasty
Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty
1 other identifier
interventional
202
1 country
1
Brief Summary
To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
November 20, 2025
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
Study Completion
Last participant's last visit for all outcomes
January 1, 2028
February 5, 2026
February 1, 2026
1.1 years
November 15, 2025
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Number of Days to Identification of Delayed Wound Healing
Delayed wound healing is defined as the presence of one or more of the following clinical signs: drainage from wound, wound dehiscence, and superficial surgical site infection. Assessment is performed by clinical examination and documentation in the postoperative period. The outcome is measured in number of days from surgery to identification of delayed healing
Up to 14 days
Patient satisfaction with scaring as measured by Patient Scar Assessment Scale
Using the Patient Scar Assessment Scale, which is a validated plastic surgery tool for evaluating scars from the patient's perspective. Measured with a scale from 0 to 10, higher score indicates less satisfaction.
Up to 12 months
Scar cosmesis as measured by Observer Scar Assessment Scale
Using the Observer Scar Assessment Scale, which is a validated plastic surgery tool for evaluating scars from the observer perspective. Measured with a scale from 0 to 10, higher score indicates worse scar cosmesis.
Up to 12 months
Secondary Outcomes (5)
Number of Participants Reporting Lateral Femoral Cutaneous Nerve (LFCN) Symptoms
Up to 6 months
Hip Disability and Osteoarthritis Outcome Score (HOOS) - Patient-Reported Outcome
Up to 12 months
Number of Intraoperative fractures
Up to 3 hours (duration of surgery)
Length of surgery
Up to 3 hours
Number of Postoperative Complications
Up to 90 days
Study Arms (2)
Alexis Retractor
EXPERIMENTALSubjects in this arm will undergo surgery using the Alexis wound retractor.
Non-Alexis Retractor
ACTIVE COMPARATORSubjects in this arm will undergo surgery using a standard retractor that does not include the Alexis device.
Interventions
A conventional surgical retractor used during procedures without the features of the Alexis device
A surgical device used to retract tissue during procedures, designed to reduce wound trauma and improve healing
Eligibility Criteria
You may qualify if:
- Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty
- Patients undergoing primary total hip arthroplasty
You may not qualify if:
- Patients with history of prior open surgery on the affected hip
- Patients with history of prior total hip arthroplasty on the contralateral hip
- Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33125, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victor H Hernandez, MD, MSc
University of Miami Department of Orthopaedics
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Orthopaedic Surgery
Study Record Dates
First Submitted
November 15, 2025
First Posted
November 20, 2025
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share